ReviewWorld journal of gastrointestinal surgery2016
Duodenal adenocarcinoma: Advances in diagnosis and surgical management.
Review in World journal of gastrointestinal surgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
64 citing papers in PubMed, 105 citations in OpenAlex.
- Article
- Article
- Primary duodenal carcinoma presenting as subacute intestinal obstruction: Diagnostic and surgical challenge.Radiology case reports · 2026Article
- Synchronous medullary carcinoma of the pancreas and non-ampullary duodenal adenocarcinoma.Archive of clinical cases · 2026Article
- Can duodenal resection be a valid alternative to pancreatoduodenectomy for nonampullary duodenal tumors?Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery · 2026Article
- Pancreaticoduodenectomy for Mass-Forming Localized Duodenal Amyloidosis: A Case Report.Surgical case reports · 2026Article
- Outcomes and Limitations of Duodenal Endoscopic Submucosal Dissection in the United States.Digestive diseases and sciences · 2025Article
- Duodenal Tumor Presenting With Persistent Vomiting: Diagnostic and Therapeutic Challenges.Cureus · 2025Article
- Primary adenocarcinoma of duodenal bulb mimicking a pancreatic tumor: a case report.Future science OA · 2025Article
- Proximal bowel obstruction caused by high-grade duodenal adenocarcinoma: A rare case.Annals of medicine and surgery (2012) · 2025Article
- Duodenal Bulb Adenocarcinoma: A Case Report.Cureus · 2025Article
- Long-term survival outcomes of duodenal adenocarcinoma: A cohort study with 15-year single-center experience.World journal of gastrointestinal surgery · 2025Article
- Effectiveness of Palliative Chemotherapy and Associated Prognostic Factors in Advanced Small Bowel Adenocarcinoma: A Propensity Score-Matched Analysis.Cancer management and research · 2025Article
- Jejunal Enterotomy for Specimen Retrieval in D-LECS: A Case Report.Surgical case reports · 2025Article
- Case report of distal gastrectomy applied in primary duodenal bulb adenocarcinoma.Frontiers in surgery · 2025Article
- Case Report: Abscopal effect of radiotherapy in a patient with metastatic duodenal adenocarcinoma and resistance to chemoimmunotherapy.Frontiers in immunology · 2025Article
- Simultaneous double primary malignant tumors of MSS/pMMR ascending colon cancer and MSI-H/dMMR duodenal cancer with nearly 2 years of recurrence-free survival after MDT-guided comprehensive treatment: a case report.Frontiers in oncology · 2025Article
- Article
- Duodenal adenocarcinoma at stage IV: A critical look at diagnostic pathways and treatment modalities.Radiology case reports · 2024Article
- Adenocarcinoma in the Jejunum Presenting as Acute Abdomen and Melena in an Otherwise Healthy Patient: A Case Report.Cureus · 2024Article
4 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Duodenal adenocarcinoma is a rare but aggressive malignancy. Given its rarity, previous studies have traditionally combined duodenal adenocarcinoma (DA) with either other periampullary cancers or small bowel adenocarcinomas, limiting the available data to guide treatment decisions. Nevertheless, management primarily involves complete surgical resection when technically feasible. Surgery may require pancreaticoduodenectomy or segmental duodenal resection; either are acceptable options as long as negative margins are achievable and an adequate lymphadenectomy can be performed. Adjuvant chemotherapy and radiation are important components of multi-modality treatment for patients at high risk of recurrence. Further research would benefit from multi-institutional trials that do not combine DA with other periampullary or small bowel malignancies. The purpose of this article is to perform a comprehensive review of DA with special focus on the surgical management and principles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.